BNP Paribas Financial Markets
RARX

BNP Paribas Financial Markets’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

BNP Paribas Financial Markets’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19,502
Closed -$936K – 4463
2020
Q1 		$936K Buy
19,502
+15,411
+377% +$717K ﹤0.01% 1957
2019
Q4 		$192K Sell
4,091
-912
-18% -$40.3K ﹤0.01% 2974
2019
Q3 		$118K Buy
5,003
+2,901
+138% +$86K ﹤0.01% 3041
2019
Q2 		$63.2K Sell
2,102
-1,815
-46% -$41.6K ﹤0.01% 3281
2019
Q1 		$87.7K Buy
+3,917
New +$84.2K ﹤0.01% 3201
2018
Q4 		– Sell
-1,546
Closed -$28K – 4491
2018
Q3 		$28K Buy
1,546
+187
+14% +$2.22K ﹤0.01% 3279
2018
Q2 		$13.5K Sell
1,359
-2,809
-67% -$19.4K ﹤0.01% 3656
2018
Q1 		$22.1K Buy
4,168
+1,649
+65% +$11.8K ﹤0.01% 3905
2017
Q4 		$21.4K Buy
2,519
+1,293
+105% +$15.9K ﹤0.01% 3951
2017
Q3 		$17.9K Sell
1,226
-63
-5% -$952 ﹤0.01% 3645
2017
Q2 		$24.2K Buy
1,289
+1,219
+1,741% +$27.5K ﹤0.01% 3554
2017
Q1 		$1.49K Buy
+70
New +$1.34K ﹤0.01% 3617

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

BNP Paribas Financial Markets's RARX Position: Q2 2020 in Review

BNP Paribas Financial Markets sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 19,502 shares — an estimated $936K sold.

BNP Paribas Financial Markets first reported a position in RARX in Q1 2017 and held it in 12 quarters. The position peaked at $936K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • BNP Paribas Financial Markets reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 19,502 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $936K.
  • BNP Paribas Financial Markets first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 12 quarters.
  • BNP Paribas Financial Markets's Ra Pharmaceuticals, Inc. Common Stock position peaked at $936K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.